| Literature DB >> 29599723 |
Yan Liu1,2, Erchao Li1, Chang Xu2, Yujie Su2, Jian G Qin3, Liqiao Chen2, Xiaodan Wang2.
Abstract
The fish brain plays an important role in controlling growth, development, reproduction, and adaptation to environmental change. However, few studies stem from the perspective of whole transcriptome change in a fish brain and its response to long-term hypersaline stress. This study compares the differential transcriptomic responses of juvenile Nile tilapia (Oreochromis niloticus) maintained for 8 weeks in brackish water (16 practical salinity units, psu) and in freshwater. Fish brains from each treatment were collected for RNA-seq analysis to identify potential genes and pathways responding to hypersaline stress. A total of 27,089 genes were annotated, and 391 genes were expressed differently in the salinity treatment. Ten pathways containing 40 differentially expressed genes were identified in the tilapia brain. Antigen processing and presentation and phagosome were the two principally affected pathways in the immune system. Thirty-one of 40 genes were involved in various expressions associated with environmental information processing pathways such as neuroactive ligand-receptor interaction, cytokine-cytokine receptor interaction, the Jak-STAT signaling pathway, cell adhesion molecules (CAMs), and the PI3K-Akt signaling pathway, which are the upstream pathways for modulation of immunity and osmoregulation. The most-changed genes (>5-fold) were all down-regulated, including four growth hormone/prolactin gene families, i.e., prolactin precursor (-10.62), prolactin-1 (-11), somatotropin (-10.15), somatolactin-like (-6.18), and two other genes [thyrotropin subunit beta (-7.73) and gonadotropin subunit beta-2 (-5.06)] that stimulated prolactin release in tilapia. The downregulation pattern of these genes corroborates the decrease in tilapia immunity with increasing salinity and reveals an adaptive mechanism of tilapia to long-term hypersaline stress. Ovarian steroidogenesis, isoquinoline alkaloid biosynthesis, and phenylalanine metabolism are the three important pathways in the response of the fish to long-term hypersaline stress. This study has identified several pathways and relevant genes that are involved in salinity regulation in a euryhaline fish and provides insight into understanding regulatory mechanisms of fish to salinity change.Entities:
Keywords: gene; immunity; osmoregulation; pathway; salinity; transcriptome
Year: 2018 PMID: 29599723 PMCID: PMC5862863 DOI: 10.3389/fphys.2018.00219
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Summary statistics of the RNA-seq data of brains from Nile tilapia grown for 49 days in freshwater and brackish water with a salinity of 16 psu.
| Total reads (× 106) | 54.52 | 58.83 | 60.26 | 57.90 | 63.26 | 57.88 | 352.65 | 58.775 |
| Total reads after trimming (× 106) | 53.24 | 56.97 | 58.86 | 56.63 | 61.96 | 56.68 | 344.34 | 57.39 |
| Reads filtered (%) | 97.66 | 96.84 | 97.68 | 97.81 | 97.93 | 97.92 | 97.64 | 97.64 |
| Total base (bp, × 109) | 8.23 | 8.88. | 9.10 | 8.74 | 9.55 | 8.74 | 53.24 | 8.87 |
| Total base after trimming (bp, × 109) | 7.83 | 8.33 | 8.66 | 8.33 | 9.12 | 8.34 | 50.61 | 8.435 |
| Base filtered (%) | 95.10 | 93.75 | 95.13 | 95.31 | 95.45 | 95.47 | 95.06 | 95.04 |
| Mapped reads (× 106) | 48.68 | 52.42 | 54.03 | 51.96 | 56.87 | 52.01 | 315.97 | 52.66 |
| Mapping rate (%) | 91.44 | 92.01 | 91.80 | 91.75 | 91.79 | 91.75 | 91.76 | 91.76 |
Figure 1Overview of fold changes in gene expression in this study. The y-axis indicates the statistical p-value, and the x-axis indicates the fold changes of genes.
Figure 2An overview of the significantly affected pathways from KEGG analysis in this study. The y-axis indicates specific pathways, and the x-axis indicates the enrichment ratio. The size of the colored dots indicates the number of significantly changed genes involved into each corresponding pathway, and pathways with larger-sized dots contain a higher number of genes. The color of the dots shows the –log p-value of the pathways.
Significantly changed pathways obtained with KEGG, using the significantly changed genes from brains of Nile tilapia grown for 49 days in brackish water with a salinity of 16 psu vs. those of tilapia in freshwater.
| Antigen processing and presentation | ko04612 | 8 | 163 | 0.001 | 19932|2770|3482|2754|3460 (up-regulated) 20042|1466|18447 (down-regulated) | Immune system | Organismal systems |
| Phagosome | ko04145 | 10 | 285 | 0.002 | 3482|2754|3460|19932|2770 (up-regulated) 14114|1466|18447|20042|12747 (down-regulated) | Transport and catabolism | Cellular processes |
| Neuroactive ligand-receptor interaction | ko04080 | 14 | 552 | 0.006 | 24421|14071|5826|5357|6467|4654|1493|6469|9191 (up-regulated) 25798|16886|18430|7953|16259 (down-regulated) | Signaling molecules and interaction | Environmental information processing |
| Ovarian steroidogenesis | ko04913 | 4 | 73 | 0.012 | 26630|1493|2608|5826 (up-regulated) | Endocrine system | Organismal systems |
| Cytokine-cytokine receptor interaction | ko04060 | 8 | 272 | 0.016 | 6469|5357|6467|9191|11230 (up-regulated) 8910|18024|4273 (down-regulated) | Signaling molecules and interaction | Environmental information processing |
| Jak-STAT signaling pathway | ko04630 | 6 | 176 | 0.019 | 5357|6467|9191|6469 (up-regulated) 18024|4273 (down-regulated) | Signal transduction | Environmental information processing |
| Isoquinoline alkaloid biosynthesis | ko00950 | 2 | 19 | 0.024 | 14747|11903 (down-regulated) | Biosynthesis of other secondary metabolites | Metabolism |
| Phenylalanine metabolism | ko00360 | 2 | 20 | 0.026 | 14747|11903 (down-regulated) | Amino acid metabolism | Metabolism |
| Cell adhesion molecules (CAMs) | ko04514 | 8 | 324 | 0.039 | 3482|1472|19932 (up-regulated) 13988|15142|1466|18447|15920 (down-regulated) | Signaling molecules and interaction | Environmental information processing |
| PI3K-Akt signaling pathway | ko04151 | 10 | 455 | 0.044 | 6469|9191|6467 (up-regulated) 2865|14114|7953|141|2145|1075|5357 (down-regulated) | Signal transduction | Environmental information processing |
Significantly changed genes and KEGG pathways in the brains of Nile tilapia grown for 49 days in brackish water vs. in freshwater.
| ENSONIG00000001466 | 1.57 | 1.76E-02 | MHC1 | Major histocompatibility complex class I-related gene protein-like |
| ENSONIG00000001472 | −1.39 | 8.17E-04 | MAG, GMA, SIGLEC4 | Sialic acid-binding Ig-like lectin 10-like |
| ENSONIG00000001493 | −5.06 | 3.79E-05 | LHB | Gonadotropin subunit beta-2 |
| ENSONIG00000003482 | −3.47 | 5.30E-03 | MHC1 | H-2 class I histocompatibility antigen |
| ENSONIG00000004273 | 1.46 | 2.84E-02 | IL10RB | Interferon alpha/beta receptor 1-like isoform X1 |
| ENSONIG00000004654 | −1.29 | 2.54E-02 | GZMA | Granzyme K-like |
| ENSONIG00000005357 | −6.18 | 2.78E-04 | GH | Somatolactin-like |
| ENSONIG00000005826 | −3.28 | 3.72E-04 | FSH | FSH beta subunit precursor |
| ENSONIG00000006467 | −10.62 | 3.18E-06 | PRL | Prolactin precursor |
| ENSONIG00000006469 | −11 | 8.13E-06 | PRL | Prolactin-1 |
| ENSONIG00000007953 | 2.19 | 4.45E-02 | LPAR6, P2RY5 | Lysophosphatidic acid receptor 6-like |
| ENSONIG00000008910 | 1.51 | 2.61E-02 | TNFRSF14, HVEM | Tumor necrosis factor receptor superfamily member 5-like |
| ENSONIG00000009191 | −10.15 | 6.21E-06 | GH | Somatotropin |
| ENSONIG00000011230 | −2.19 | 1.27E-03 | IL1B | Interleukin-1 beta-like |
| ENSONIG00000013988 | 1.39 | 2.28E-02 | PTPRF, LAR | Receptor-type tyrosine-protein phosphatase F-like |
| ENSONIG00000014071 | −1.7 | 1.10E-04 | DRD3 | D(3) dopamine receptor-like isoformX2 |
| ENSONIG00000015142 | 1.09 | 2.41E-02 | PVRL1 | Poliovirus receptor-related protein 2-like |
| ENSONIG00000015920 | 1.04 | 4.34E-03 | VCAN, CSPG2 | Versican core protein |
| ENSONIG00000016259 | 2.69 | 5.28E-03 | TAAR | Trace amine-associated receptor 7g |
| ENSONIG00000016886 | 1.08 | 2.70E-02 | CYSLTR1 | Cysteinyl leukotriene receptor 1-like |
| ENSONIG00000018024 | 1.05 | 4.20E-02 | IL22, IL-TIF | IL-22 |
| ENSONIG00000018430 | 3.24 | 5.84E-03 | CHRNB1 | Acetylcholine receptor subunit beta-like |
| ENSONIG00000018447 | 2.83 | 7.73E-04 | MHC1 | Major histocompatibility complex class I |
| ENSONIG00000019932 | −1.97 | 7.47E-04 | MHC2 | H-2 class II histocompatibility antigen |
| ENSONIG00000024421 | −7.73 | 2.66E-04 | TSHB | Thyrotropin subunit beta |
| ENSONIG00000025798 | 1.69 | 3.55E-02 | P2RY14 | Uncharacterized protein |
| ENSONIG00000000141 | −1.68 | 4.12E-03 | COL9A | Collagen alpha-1(IX) chain |
| ENSONIG00000001075 | 1.52 | 1.70E-02 | COL4A | Collagen alpha-4(IV) chain-like isoform X1 |
| ENSONIG00000002145 | 1.9 | 2.74E-02 | GNG12 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12-like |
| ENSONIG00000002865 | 1.26 | 1.34E-03 | LAMA3_5 | Laminin subunit alpha-3-like |
| ENSONIG00000004273 | 1.46 | 2.84E-02 | IL10RB | Interferon alpha/beta receptor 1-like isoform X1 |
| ENSONIG00000005357 | −6.18 | 2.78E-04 | GH | Somatolactin-like |
| ENSONIG00000006467 | −10.62 | 3.18E-06 | PRL | Prolactin precursor |
| ENSONIG00000006469 | −11 | 8.13E-06 | PRL | Prolactin-1 |
| ENSONIG00000007953 | 2.19 | 4.45E-02 | LPAR6, P2RY5 | Lysophosphatidic acid receptor 6-like |
| ENSONIG00000009191 | −10.15 | 6.21E-06 | GH | Somatotropin |
| ENSONIG00000014114 | 2.69 | 5.96E-04 | TLR2 | Toll-like receptor 2 |
| ENSONIG00000018024 | 1.05 | 4.20E-02 | IL22, IL-TIF | IL-22 |
| ENSONIG00000001466 | 1.57 | 1.76E-02 | MHC1 | Major histocompatibility complex class I-related gene protein-like |
| ENSONIG00000002754 | −1.26 | 1.13E-02 | CTSS | Cathepsin S-like |
| ENSONIG00000002770 | −1.24 | 1.39E-02 | CTSS | Cathepsin K-like |
| ENSONIG00000003460 | −1.28 | 4.99E-02 | CTSL | Cathepsin L1 |
| ENSONIG00000003482 | −3.47 | 5.30E-03 | MHC1 | H-2 class I histocompatibility antigen |
| ENSONIG00000012747 | 1.11 | 2.95E-03 | TUBA | Interferon-induced protein 44-like isoform X3 |
| ENSONIG00000014114 | 2.69 | 5.96E-04 | TLR2 | Toll-like receptor 2 |
| ENSONIG00000018447 | 2.83 | 7.73E-04 | MHC1 | Major histocompatibility complex class I |
| ENSONIG00000019932 | −1.97 | 7.47E-04 | MHC2 | H-2 class II histocompatibility antigen |
| ENSONIG00000020042 | 2.79 | 6.26E-03 | ABCB3, TAP2 | Antigen peptide transporter 2-like |
| ENSONIG00000001466 | 1.57 | 1.76E-02 | MHC1 | Major histocompatibility complex class I-related gene protein-like |
| ENSONIG00000002754 | −1.26 | 1.13E-02 | CTSS | Cathepsin S-like |
| ENSONIG00000002770 | −1.24 | 1.39E-02 | CTSS | Cathepsin K-like |
| ENSONIG00000003460 | −1.28 | 4.99E-02 | CTSL | Cathepsin L1 |
| ENSONIG00000003482 | −3.47 | 5.30E-03 | MHC1 | H-2 class I histocompatibility antigen |
| ENSONIG00000018447 | 2.83 | 7.73E-04 | MHC1 | Major histocompatibility complex class I |
| ENSONIG00000019932 | −1.97 | 7.47E-04 | MHC2 | H-2 class II histocompatibility antigen |
| ENSONIG00000020042 | 2.79 | 6.26E-03 | ABCB3, TAP2 | Antigen peptide transporter 2-like |
| ENSONIG00000001493 | −5.06 | 3.79E-05 | LHB | Gonadotropin subunit beta-2 |
| ENSONIG00000002608 | −1.22 | 4.84E-02 | CYP2J | Cytochrome P450 2J2 |
| ENSONIG00000005826 | −3.28 | 3.72E-04 | FSH | FSH beta subunit precursor |
| ENSONIG00000026630 | −1.06 | 3.76E-02 | CYP2J | Cytochrome P450 2J2-like |
| ENSONIG00000011903 | 1.27 | 3.90E-03 | AOC3, AOC2, tynA | Primary amine oxidase, liver isozyme-like isoform X1 |
| ENSONIG00000014747 | 1.77 | 1.39E-02 | IL4I1 | L-amino-acid oxidase-like isoform X1 |
Figure 3Analysis of genes involved in different pathways under various categories (A) and co-expression network of significantly changed genes (B). In (A), the circles with different colors show the pathways in different categories, and the circle size is positively correlated with the number of genes in each corresponding category. In (B), green indicates down-regulated genes, while red indicates up-regulated genes. The dot size is positively correlated with the fold change of genes. Values inside all circles and dots are the number of genes shown in Table 3.